ALLMedicine™ Alopecia Center
Research & Reviews 3,210 results
https://doi.org/10.1002/jcph.2088
Journal of Clinical Pharmacology; Krysiak R, Kowalcze K et. al.
May 24th, 2022 - Males with early-onset androgenic alopecia are characterized by elevated androgen levels. The aim of the present study was to investigate whether the presence of this condition modulates the impact of metformin on pituitary hormone production. Thi...
https://doi.org/10.1016/j.jaad.2022.05.026
Journal of the American Academy of Dermatology; Sanabria BD, Palmegiani E et. al.
May 22nd, 2022 - Prospective cardiovascular evaluation with 24-h Holter and 24-h ambulatory blood pressure monitoring in men using 5 mg oral minoxidil for androgenetic alopecia.|2022|Sanabria BD,Palmegiani E,Seron AF,Perdomo YC,Miot HA,|
https://doi.org/10.1016/j.jaad.2022.05.023
Journal of the American Academy of Dermatology; Collins M, Ali S et. al.
May 20th, 2022 - Retrospective review of adverse events associated with oral hydroxychloroquine use in patients with cicatricial alopecia.|2022|Collins M,Ali S,Wiss IP,Senna MM,|
https://doi.org/10.55563/clinexprheumatol/4k3gau
Clinical and Experimental Rheumatology; Zhao X, Li C et. al.
May 18th, 2022 - In this study, we aimed to explore the expression of the Aicardi-Goutières syndrome (AGS) mutant gene SAMHD1 in paediatric-onset systemic lupus erythematosus (pSLE), its correlations with clinical and laboratory parameters, and the relationship be...
https://doi.org/10.1111/jocd.15095
Journal of Cosmetic Dermatology; Hacınecipoğlu F, Gönül M et. al.
May 18th, 2022 - There may be an association between increased intestinal permeability and the progression of alopecia areata (AA). The present study aimed to investigate the role of intestinal permeability in the etiopathogenesis of AA and its association with th...
Guidelines 3 results
https://doi.org/10.1111/1346-8138.14470
The Journal of Dermatology; Manabe M, Tsuboi R et. al.
Jun 5th, 2018 - Male-pattern hair loss (MPHL, androgenetic alopecia) is a slowly progressive form of alopecia which begins after puberty. In 2010, we published the first Japanese edition of guidelines for the diagnosis and treatment of MPHL. It achieved the origi...
https://doi.org/10.1111/jdv.12034
Journal of the European Academy of Dermatology and Venere... Lee WS, Lee HJ et. al.
Nov 28th, 2012 - Androgenetic alopecia (AGA), or pattern hair loss, is a common disorder in both Asian men and women. There are several guidelines for the treatment of AGA which are suitable for Caucasian patients; however, each of these has some limitations. Furt...
https://doi.org/10.1111/j.1365-2133.2012.10955.x
The British Journal of Dermatology; Messenger AG, McKillop J et. al.
Apr 25th, 2012 - British Association of Dermatologists' guidelines for the management of alopecia areata 2012.|2012|Messenger AG,McKillop J,Farrant P,McDonagh AJ,Sladden M,|diagnosis,etiology,therapy,methods,therapeutic use,methods,methods,methods,
Drugs 295 results see all →
Clinicaltrials.gov 133 results
https://clinicaltrials.gov/ct2/show/NCT05380427
May 18th, 2022 - To evaluate the safety and tolerability of TDM-105795 administered topically in healthy male subjects with androgenetic alopecia(AGA ). To evaluate the pharmacokinetics (PK)/Pharmacodynamics (PD) of TDM-105795 following administration of a single ...
https://clinicaltrials.gov/ct2/show/NCT05051761
May 18th, 2022 - This is a multi-center Phase 3 study to evaluate the safety and effectiveness of an investigational study drug (called Jaktinib) in adults (≥18 years and <65 years) who have 50% or greater scalp hair loss. The study is placebo-controlled, meaning ...
https://clinicaltrials.gov/ct2/show/NCT04341363
May 13th, 2022 - Proposed is an open label trial of tattoo machine microneedling in ten patients with androgenic alopecia. Ten healthy male patients older than 18 years will undergo 6 microneedling sessions. Over the course of six months, subjects will undergo up ...
https://clinicaltrials.gov/ct2/show/NCT05365360
May 9th, 2022 - Androgenetic alopecia (AGA) is a prevalent disease, occurring in 80% of Caucasian men and 50% of Caucasian women by age 701. Treatments for AGA are limited, and presently the only FDA-approved medications for AGA are topical minoxidil and oral fin...
https://clinicaltrials.gov/ct2/show/NCT03240627
Apr 12th, 2022 - Methods / trial design: Randomised, double-blind, vehicle-controlled multicentre trial in parallel groups. At screening (Visit 0), subjects will discontinue their previous treatment for alopecia areata, if any. Screening period will last up to 28 ...
News 595 results
https://www.medscape.com/viewarticle/974368
May 20th, 2022 - The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended approval of baricitinib, a Janus kinase (JAK) inhibitor, for the treatment of adults with severe alopecia areata (AA). The development, whi...
https://www.medscape.com/viewarticle/973864
May 12th, 2022 - Core Messages Two phase 3 studies, each running for 36 weeks, have proven the efficacy of the Janus kinase inhibitor baricitinib (Olumiant) for patients with alopecia areata. Almost a quarter of participants achieved the therapeutic aim of 80% hai...
https://www.onclive.com/view/nab-paclitaxel-plus-pembrolizumab-produces-promising-responses-in-advanced-urothelial-cancer
May 2nd, 2022 - The combination of nab-paclitaxel (Abraxane) and pembrolizumab (Keytruda) produced an encouraging overall response rate (ORR) with manageable safety in patients with advanced urothelial cancer who were refractory to platinum-based chemotherapy or ...
https://www.mdedge.com/dermatology/article/254201/hair-nails/facial-follicular-spicules-rare-cutaneous-presentation
Joy F. King, MD, PhD, Adam C. Byrd, MD et. al.
Apr 28th, 2022 - To the Editor: A 57-year-old man with hypertension, dyslipidemia, and congestive heart failure presented with a disfiguring eruption comprised of asymptomatic papules on the face that appeared 12 months post–heart transplantation. Immunosuppressiv.
https://www.onclive.com/view/targeted-treatment-boom-reshapes-differentiated-thyroid-cancer-landscape
Apr 18th, 2022 - Differentiated thyroid cancer (DTC) makes up approximately 95% of all thyroid cancers and is becoming more prevalent worldwide.1 A decade ago, treatment options for DTC were limited but today a plethora of targeted treatments are available. There ...